Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
104.7 USD | +0.07% | -1.10% | -4.84% |
May. 09 | Drugmaker Abbott India posts Q4 profit rise on higher sales | RE |
May. 08 | Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 41.7B | Sales 2025 * | 44.75B | Capitalization | 182B |
---|---|---|---|---|---|
Net income 2024 * | 5.96B | Net income 2025 * | 7.18B | EV / Sales 2024 * | 4.5 x |
Net Debt 2024 * | 5.47B | Net cash position 2025 * | 640M | EV / Sales 2025 * | 4.06 x |
P/E ratio 2024 * |
30.6
x | P/E ratio 2025 * |
26.1
x | Employees | 114,000 |
Yield 2024 * |
2.07% | Yield 2025 * |
2.21% | Free-Float | 86.95% |
Latest transcript on Abbott Laboratories
1 day | +0.07% | ||
1 week | -1.10% | ||
Current month | -1.16% | ||
1 month | -6.02% | ||
3 months | -6.32% | ||
6 months | +11.46% | ||
Current year | -4.84% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 0 M€ | +7.69% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 104.7 | +0.07% | 7,349,729 |
24-05-09 | 104.7 | -0.26% | 5,902,240 |
24-05-08 | 104.9 | -1.16% | 6,234,711 |
24-05-07 | 106.2 | +0.50% | 6,556,396 |
24-05-06 | 105.6 | -0.25% | 3,789,737 |
Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B | |
+5.22% | 22.86B |
- Stock Market
- Equities
- ABT Stock